Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
about
Pregabalin for the treatment of generalized anxiety disorder: an updateThe treatment of generalized anxiety disorder with pregabalin, an atypical anxiolyticEmerging drugs for the treatment of anxietyAnxioselective anxiolytics: on a quest for the Holy GrailThe effectiveness of anticonvulsants in psychiatric disordersSelective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Psychometric evaluation of a visual analog scale for the assessment of anxiety.Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)Pregabalin in acute and chronic pain.Pregabalin for the treatment of generalized anxiety disorder.Generalized anxiety disorder: acute and chronic treatment.Pregabalin: a review of its use in adults with generalized anxiety disorder.Pharmacological treatment for generalized anxiety disorder in adults: an update.Abuse Potential of Pregabalin: A Systematic Review.Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.Pregabalin influences insula and amygdala activation during anticipation of emotional images.Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitorsTreatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.Comorbidities in chronic neuropathic pain.Pregabalin effects on neural response to emotional faces.Comprehensive care of the epilepsy patient--control, comorbidity, and cost.Treatments for generalized anxiety disorder.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Pregabalin: a new neuromodulator with broad therapeutic indications.Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders.Diagnosis and Treatment Procedures for Patients With Anxiety Disorders by the Psychiatric Consultation Liaison Service in a General Hospital in Germany: A Retrospective AnalysisPregabalin for the treatment of generalised anxiety disorder.Effects of antiepileptic drugs on mood and behavior.Pregabalin for pain management.A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal.The diagnosis and treatment of generalized anxiety disorder.Role of pregabalin in the treatment of generalized anxiety disorderEpilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)Predictors of premature discontinuation of treatment in multiple disease statesDoes pregabalin have neuropsychotropic effects?: a short perspective.Advances in pharmacotherapy for pediatric anxiety disorders.
P2860
Q24604809-FBE05D46-8EEC-487E-A6D6-5BDD3318B769Q24658278-98D00A36-2A7C-44F5-8199-AAF63EA468C3Q28083141-8C59E66A-FB03-4EF8-8126-1C6F1BEB19A0Q28275122-5379967D-F777-42D8-A317-1BB3A236B431Q28744504-44B10050-9BDD-4DFE-854D-41A277B45F82Q28972575-847F6691-F86F-4DE4-8FC7-B27EA9DA37A2Q33642622-E3997698-65AA-437B-BC89-3366DB056904Q33949565-D05544D2-C59F-494A-902D-923212495C16Q33997934-43C0EA50-94C0-410A-93D8-D228041B03A0Q34024109-CD1DC298-9127-4421-8A23-13B40A47C93FQ34183517-A1610C55-D5EB-4C99-94FB-22093BCBF329Q34214071-202E6379-BD84-4C0D-95F9-093154B9D00EQ34259185-C9F9602D-4A1D-4781-A40B-4098354625BFQ34353112-FC263446-2250-4EFC-A166-6FE93AD28355Q34434641-0D80883C-2A76-44F6-88F0-D2CA52F9E17CQ34484276-FF03EE6F-8706-4AA5-AD26-CF6704779172Q34509031-B89962A8-88D7-48DE-B2AD-D20C063118FEQ34645876-6A208870-CE02-4E0F-A8FA-9F2035675595Q34865036-BBBD0E6F-42D9-4BB7-977D-FF677A9B43A4Q34988442-99BEBE94-CEE2-4147-9E50-AB6E3915A654Q35021417-20981675-9DBC-48E4-9D65-F07BE4A61944Q35252034-C167E1F5-3A38-442E-8741-E8C5F4A0A554Q35680402-EF7E5990-9B4A-49B8-ADDC-2A3F09255DDFQ35855502-E5D0D78E-00D9-4E28-9354-A00752224FD5Q35865168-1C87EA04-FE71-4AFC-90DE-03CAF1F6B8E4Q36107118-CDDB9B74-0A8D-4C8F-BB0D-3F0B61DC61F9Q36199036-45F790D3-9D9F-40E1-A881-A9D81E1BCCACQ36313119-ECE26A20-81C3-436E-A564-652B0D66CA7BQ36403889-CEE6EB5E-A2A9-457E-940E-72BF32A4E66AQ36518659-697F416E-AB54-49AC-A8C5-B816F7F01BE0Q36613951-47C609DA-F4B1-498E-AA79-230D3424E445Q36653769-1B7BE26E-39AA-44EE-BF6C-F4E375A05EA1Q36687433-BABDC6ED-AE85-4F22-B4EC-5EC4A9D9A770Q36797810-7924DBE5-B3C3-4352-89C4-753381FBD750Q36837462-FB04A133-8E26-4ABD-90E6-0539CECC9AA2Q37125739-DD3C7D2C-442F-4619-AB44-ED91D3FD795BQ37242260-1F6F2CAE-8D99-44D0-A0E2-D34A78E51FECQ37423705-DACC91AA-0130-4800-8C4C-2E93BB7DE263Q37484092-6B9ED053-B66B-4C7D-88F1-4B6F06071BB7Q37827822-CAA8C62A-BAAE-48A1-BAE5-32E9E3766AB7
P2860
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
@en
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
@nl
type
label
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
@en
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
@nl
prefLabel
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
@en
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
@nl
P2093
P1476
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
@en
P2093
Atul C Pande
Carol A Janney
Dan L Zimbroff
Douglas E Feltner
Jerri G Crockatt
Jonathan R T Davidson
Maria Liu-Dumaw
Peter D Londborg
Richard Weisler
Robert J Bielski
P304
P356
10.1176/APPI.AJP.160.3.533
P407
P577
2003-03-01T00:00:00Z